Modulation of cadherin and catenins expression by tumor necrosis factor-α and dexamethasone in human bronchial epithelial cells

被引:62
作者
Carayol, N [1 ]
Campbell, A [1 ]
Vachier, I [1 ]
Mainprice, B [1 ]
Bousquet, J [1 ]
Godard, P [1 ]
Chanez, P [1 ]
机构
[1] Hop Arnaud Villeneuve, Clin Malad Resp, F-34295 Montpellier 5, France
关键词
D O I
10.1165/ajrcmb.26.3.4684
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Asthma is an inflammatory disease, and the epithelial mesenchymal unit appears to be of importance in regulating the disease mechanisms. Cell-cell adhesion plays an important role in tissue morphogenesis and homeostasis and is commonly mediated by cadherins, a family of Ca2+-dependent transmembrane adhesion receptors. The cadherin family is involved in control of the cellular architecture. Proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha are Involved in asthma and may interfere with epithelial integrity. In the present study, we investigated the role of TNF-alpha and dexamethasone on the expression of E-cadherin, beta-catenin, and gamma-catenin. We used two bronchial epithelial cell models: primary small airway epithelial cell cultures and primary culture obtained from human bronchial tubes. After 48 h of TNF-alpha stimulation with or without dexamethasone expression of E-cadherin, beta-catenin and gamma-catenin were analyzed using Western blot analysis and immunofluorescence. This study showed a decrease in the expression of adhesion molecules in both epithelial cell cultures after stimulation. Dexamethasone and anti-TNF-alpha inhibited this effect. In unstimulated cells, E-cadherin and beta- and gamma-catenin expression was membranous, expressed only on the lateral cell wall with minimal cytoplasmic expression. Immunoreactivity was cytoplasmic in stimulated cells. We demonstrated, using Western blot analysis and immunofluorescence, that proinflammatory cytokines could be responsible for structural damage to the epithelium and that this process was potentially reversed by steroids.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 44 条
[21]  
KWON OJ, 1994, IMMUNOLOGY, V81, P389
[22]   Histopathologic features of early and progressive asthma [J].
Laitinen, A ;
Karjalainen, EM ;
Altraja, A ;
Laitinen, LA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (02) :S509-S513
[23]   BRONCHIAL EPITHELIAL SHEDDING IN ASTHMATICS AND NON-ASTHMATICS [J].
MONTEFORT, S ;
ROCHE, WR ;
HOLGATE, ST .
RESPIRATORY MEDICINE, 1993, 87 :9-11
[24]   THE SITE OF DISRUPTION OF THE BRONCHIAL EPITHELIUM IN ASTHMATIC AND NONASTHMATIC SUBJECTS [J].
MONTEFORT, S ;
ROBERTS, JA ;
BEASLEY, R ;
HOLGATE, ST ;
ROCHE, WR .
THORAX, 1992, 47 (07) :499-503
[25]   CILIATED CELL-DAMAGE IN THE BRONCHIAL EPITHELIUM OF ASTHMATICS AND NON-ASTHMATICS [J].
MONTEFORT, S ;
DJUKANOVIC, R ;
HOLGATE, ST ;
ROCHE, WR .
CLINICAL AND EXPERIMENTAL ALLERGY, 1993, 23 (03) :185-189
[26]   Signaling through β-catenin and Lef/Tcf [J].
Novak, A ;
Dedhar, S .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 56 (5-6) :523-537
[27]  
Perry I, 1999, LAB INVEST, V79, P1489
[28]   Immunopharmacology:: anti-inflammatory therapy targeting transcription factors [J].
Pfeilschifter, J ;
Mühl, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) :237-245
[29]  
Polakis P, 2000, GENE DEV, V14, P1837
[30]   Repair mechanisms in asthma [J].
Rennard, SI .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) :S278-S286